JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Homolya, L.
Right arrow Articles by Boucher, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Homolya, L.
Right arrow Articles by Boucher, R. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 37, 26454-26460, September 10, 1999


Nucleotide-regulated Calcium Signaling in Lung Fibroblasts and Epithelial Cells from Normal and P2Y2 Receptor (-/-) Mice*

László HomolyaDagger §, William C. WattDagger , Eduardo R. LazarowskiDagger , Beverly H. KollerDagger , and Richard C. BoucherDagger

From the Dagger  Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, North Carolina 27599 and the § Membrane Research Group of Hungarian Academy of Sciences in the National Institute of Haematology and Immunology, Budapest, H-1113, Hungary

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

To test for the role of the P2Y2 receptor (P2Y2-R) in the regulation of nucleotide-promoted Ca2+ signaling in the lung, we generated P2Y2-R-deficient (P2Y2-R(-/-)) mice and measured intracellular Ca2+i responses (Delta Ca2+i) to nucleotides in cultured lung fibroblasts and nasal and tracheal epithelial cells from wild type and P2Y2-R(-/-) mice. In the wild type fibroblasts, the rank order of potencies for nucleotide-induced Delta Ca2+i was as follows: UTP >=  ATP >> ADP > UDP. The responses induced by these agonists were completely absent in the P2Y2-R(-/-) fibroblasts. Inositol phosphate responses paralleled those of Delta Ca2+i in both groups. ATP and UTP also induced Ca2+i responses in wild type airway epithelial cells. In the P2Y2-R(-/-) airway epithelial cells, UTP was ineffective. A small fraction (25%) of the ATP response persisted. Adenosine and alpha ,beta -methylene ATP were ineffective, and ATP responses were not affected by adenosine deaminase or by removal of extracellular Ca2+, indicating that neither P1 nor P2X receptors mediated this residual ATP response. In contrast, 2-methylthio-ADP promoted a substantial Ca2+i response in P2Y2-R(-/-) cells, which was inhibited by the P2Y1 receptor antagonist adenosine 3'-5'-diphosphate. These studies demonstrate that P2Y2-R is the dominant purinoceptor in airway epithelial cells, which also express a P2Y1 receptor, and that the P2Y2-R is the sole purinergic receptor subtype mediating nucleotide-induced inositol lipid hydrolysis and Ca2+ mobilization in mouse lung fibroblasts.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Extracellular ATP induces a wide variety of responses in many cell types, including muscle contraction and relaxation, vasodilation, neurotransmission, platelet aggregation, ion transport regulation, and cell growth (1-3). The cell surface receptors mediating these diverse effects of ATP were originally termed P2 purinoceptors to distinguish them from the adenosine-activated P1 purinoceptors (4). Subsequently, pyrimidine nucleotides were also shown to regulate a broad range of cell functions, leading to speculation about the existence of separate pyrimidoceptors (5, 6). It is likely, however, that a common receptor for uridine and adenine nucleotides is present in many cell types, including neutrophils, pituitary cells, skin fibroblasts, smooth muscle cells, and specific endothelial and epithelial cell types (2). This receptor was originally named the P2U purinoceptor but has been subsequently reclassified as the P2Y2 receptor (P2Y2-R).1 The cloning of the murine P2Y2-R gene (7) and its human counterpart (8) made possible the definitive identification of this signaling protein as a G-protein and phospholipase C-coupled receptor that is equipotently activated by ATP and UTP but not by diphosphate nucleotides (9-11).

The lack of specific agonists or antagonists for the growing number of nucleotide receptor subtypes (e.g. seven P2X and five P2Y receptors have been identified to date (12, 13)) constitutes a major obstacle in identifying the specific nucleotide receptor mediating a given cellular function. One example of the difficulty in assigning receptor subtypes to cellular responses is illustrated in studies of fibroblasts. Following original studies by Okada et al. (14), who observed that ATP induced change in the membrane potential of mouse L cells and human fibroblasts, a variety of adenosine- and ATP-induced responses in fibroblasts were reported. These actions of adenosine and ATP, which include regulation of cell growth, cytoskeletal contraction, Ca2+ efflux, and LDH and nucleotide release (15-19), were proposed to be mediated by A1, A2, P2X, P2Z (in current terminology P2X7), and P2Y1 receptors (15-23). In one study with human skin fibroblasts, actions of ATP on Ca2+ mobilization and phospholipase C activity were mimicked by UTP (24), although no further characterization of the receptor(s) mediating UTP responses in fibroblasts was provided.

The effects of extracellular nucleotides have also been extensively studied on airway epithelia, and attempts have been made to link the cellular responses to specific nucleotide receptors. Both ATP and UTP equipotently regulate epithelial electrolyte and water transport (3, 25), trigger mucin secretion (26, 27), and increase ciliary beat frequency (28-30). ATP and UTP equipotently stimulate inositol phosphate formation (29) and Ca2+i mobilization and exhibit cross-desensitization (3). These data suggest that a common receptor for ATP and UTP is expressed on the airway epithelia, which pharmacologically is most likely to be the P2Y2-R. However, receptors that are activated by UDP (31) and adenosine (32) may also be expressed on these cells and thus complicate this analysis.

In this study, we generated a mouse line carrying a mutant P2Y2 allele. We used these mice to examine the relative role of P2Y2-R in the nucleotide-promoted Ca2+ signaling in mouse lung fibroblasts and airway epithelial cells. The role of P2Y2-R was tested by comparison of nucleotide-stimulated Ca2+i responses in cells from P2Y2-R (-/-) mice with those from wild type animals. In the accompanying paper (33), the role of P2Y2-R in mediating Cl- secretory responses in freshly excised tracheal, gallbladder, and jejunal tissues is described.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Generation of P2Y2-R-deficient Mice-- A targeting vector was designed such that DNA corresponding to base pairs 552-1149 of the published P2Y2-R cDNA was replaced with the neomycin gene upon integration of the targeting plasmid into the genome by homologous recombination. The targeting plasmid contains two regions of DNA with homology to the endogenous locus. The targeting vector was constructed by cloning two genomic DNA fragments into the JNS2 vector: a 2500-base pair fragment extending from an XhoI site in the 5' region of the gene to a SmaI site located at base pair 552 of the published cDNA and a fragment extending 6500 bases 3' from the EagI site at base pair 1149 of the coding sequence. The targeting vector was electroporated into E142aTG cells, and resulting neomycin- and gancyclovir-resistant colonies were isolated. DNA from surviving colonies was isolated, digested with BamHI, and analyzed by Southern blot analysis using a probe located immediately upstream of the P2Y2-R genomic fragments not included in the targeting vector. Chimeric mice were generated with P2Y2-R-targeted E142aTG cell lines and were bred to B6D2 mice. Offspring were identified by Southern blot analysis of tail DNA, using probes described above.

Total cellular RNA was isolated from kidneys of P2Y2-R(+/+) and P2Y2-R(-/-) mice with RNAzol B (TelTest, Inc., Friendswood, TX), as per the manufacturer's instructions. Twenty µg of RNA were electrophoresed in a 1.2% agarose formaldehyde gel, blotted to an Immobilon-NC transfer membrane (Millipore Corp., Bedford, MA), and UV-cross-linked. The membranes were hybridized with a 32P-labeled P2Y2-R cDNA for 1 h at 68 °C using Quikhyb reagent (Stratagene, La Jolla, CA), and blots were washed twice with 2× SSC, 0.1% SDS and once with 0.2× SSC, 0.1%SDS at 42 °C for 15 min each. The P2Y2-R cDNA corresponds to base pairs 267-1097.

For histological analysis, all animals were exsanguinated by severing the aorta after receiving an intraperitoneal injection of a lethal dose of chloral hydrate (1 ml of a 20 mg/ml solution). Organs were immersed in 10% phosphate-buffered neutral formalin (pH 7.0) for at least 24 h. The organs then were embedded in paraffin, dehydrated, and sectioned for histological analysis with hematoxylin and eosin.

Adult mice (wild type and P2Y2(-/-)) of both sexes were used in this investigation. All animals were bred and raised at the University of North Carolina at Chapel Hill. All mice were allowed food and water ad libitum until euthanized.

Cell Culture-- Wild type and P2Y2-R(-/-) mice were euthanized with 100% CO2. Lung fibroblasts were isolated by mincing freshly excised lung parenchyma into ~1-mm3 pieces and establishing explant cultures on plastic tissue culture plates in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Outgrowth fibroblasts were harvested with 0.1% trypsin plus 1 mM EDTA in phosphate-buffered saline 1-3 weeks after initial plating. The cells were seeded on glass coverslips coated with 0.3 mg/ml Vitrogen (Collagen Biomaterials, CA) and cultured for 36-48 h. Nearly confluent cultures were used for study.

To isolate epithelial cells, the trachea and nasal turbinates were removed from the animals and dissected free of blood vessels and connective tissues. The airway epithelial cells were disaggregated from the tissues by a 4-h treatment with 0.1% protease XIV (Sigma), epithelial cells isolated by centrifugation, and cells were seeded at a 5 × 105 cells/cm2 density on Vitrogen-coated glass coverslips. The cells were allowed to attach for 24 h in Ham's F-12-based medium containing 10 µg/ml insulin, 5 µg/ml transferrin, 1 µM hydrocortisone, 30 nM triiodothyronine, 25 ng/ml epidermal growth factor, 3.75 µg/ml endothelial cell growth substance, 0.8 mM Ca2+ (total), and an equal amount of 3T3 fibroblast-conditioned Dulbecco's modified Eagle medium containing 2% fetal bovine serum, following which the cultures were gently washed and maintained for an additional 24-36 h before study. Only well attached cell clusters containing equal numbers of ciliated and nonciliated cells were used for Ca2+i studies.

Ca2+i Measurements-- The cell cultures were washed with hormone-free Ham's F-12 medium and incubated with 3 µM Fura-2/AM for 30 min at 37 °C. After the loading period, the cells were washed twice with Ringer solution (130 mM Na+, 128 mM Cl-, 5 mM K+, 1.3 mM Ca2+, 1.3 mM Mg2+, 5 mM glucose, and 10 mM Hepes, pH 7.4) and mounted in a microscope chamber. The fluorescence (>450 nm) of 30-50 cells was alternately acquired at 340- and 380-nm excitation by a RatioMaster RM-D microscope fluorimetry system (Photon Technology Inc., Monmouth Junction, NJ) at room temperature. A Zeiss Axiovert 35 microscope and a Nikon UV-F × 100 (1.3) glycerol immersion objective were used. After each experiment, the cells were lysed with 40 µM digitonin, and the background fluorescence was determined by quenching technique using 4 mM MnCl2.

Inositol Phosphate Studies-- Inositol phosphate measurements were performed as described previously (34). In brief, cells grown on Vitrogen-coated glass coverslips were labeled overnight with 5 µCi/ml myo-[3H]inositol in inositol-free Dulbecco's modified Eagle's medium containing 4.5 g/liter glucose. The cells were then preincubated with 10 mM LiCl for 15 min and challenged with agonist for an additional 15 min. The incubations were terminated by the addition of 5% ice-cold trichloroacetic acid. The accumulated [3H]inositol phosphates were separated on Dowex AG1-X8 anion exchange columns and quantified in a scintillation counter (31).

Reagents-- Hormones for cell culture were purchased from Collaborative Research, Inc. (Bedford, MA) with the exception of triiodothyronine, which was from Sigma; other cell culture materials were purchased from Life Technologies, Inc. Molecular biology grade ATP and UTP were purchased from Amersham Pharmacia Biotech (Uppsala, Sweden). Hexokinase, UDP, ADP, and adenosine were from Roche Molecular Biochemicals. 2-methylthio-ATP (2-MeSATP), 2-methylthio-ADP (2-MeSADP), alpha ,beta -methylene ATP (alpha ,beta -meATP), and digitonin were obtained from RBI (Natick, MA). Fura-2/AM, Fura-2 pentapotassium salt, and Ca2+ calibration buffers were purchased from Molecular Probes, Inc. (Eugene, OR). myo-[3H]inositol (20 Ci/mmol) was from ARC (St. Louis, MO). All other chemicals were purchased from Sigma. To remove triphosphate contamination from diphosphate nucleotides, 1 mM stock solutions of UDP, ADP, and 2-MeSADP were pretreated with 10 units/ml hexokinase for 30 min at 37 °C in the presence of 5 mM glucose (10).

Data Analysis-- For Ca2+i measurements, the background corrected ratio values (340/380) were calibrated by using the formula originally proposed by Grynkiewicz et al. (35). The optical parameters of the system, Rmax, Rmin, and Kd values were determined by using 1 µM Fura-2 free acid and a series of Ca2+ buffers. Differences between the peak and basal Ca2+i concentration were plotted. The data are presented as mean ± S.E. For comparisons, the mean values were analyzed by unpaired t tests. The significant differences (p < 0.05) are indicated by asterisks.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Generation of P2Y2-R-deficient Mice-- Mice deficient in P2Y2-R were generated by targeted mutagenesis of the P2Y2-R gene in mouse embryonic stem cells (Fig. 1A). RNA isolated from kidneys of a P2Y2-R(+/+) and P2Y2-R(-/-) mouse confirmed the complete loss of P2Y2-R in the P2Y2 (-/-) mouse (Fig. 1B). Mice homozygous for the mutant P2Y2-R allele were obtained at the expected frequency, were fertile, and could not be distinguished from wild type littermates. No differences were seen on histological analysis of all organs analyzed, including the kidney, heart, testes, pancreas, liver, trachea, lungs, salivary glands, and gastrointestinal tract.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Targeted disruption of the P2Y2-R gene. A, construction of the P2Y2-R targeting vector. B, confirmation of targeting by Northern blot analysis. RNA was generated from kidneys of a P2Y2-R(+/+) and a P2Y2-R(-/-) mouse. P2Y2-R is present in the kidneys of the wild type mouse but is absent in the kidneys of the P2Y2-R(-/-) mouse. B, BamH1; E, EcoRI; S, SmaI; X, XbaI; N, NotI.

Effects of Nucleotides on Inositol Phosphate Accumulation and Intracellular Ca2+ Levels in Murine Lung Fibroblasts-- The effects of nucleotides were studied in cultured lung fibroblasts isolated from wild type and P2Y2-R(-/-) mice. Changes in the intracellular Ca2+ concentration ([Ca2+]i) were monitored by using Fura-2 fluorescent indicator, and nucleotide-induced [3H]inositol phosphate formation was measured in myo-[3H]inositol-labeled cells (Fig. 2). In wild type fibroblasts, UTP and ATP promoted dose-dependent Ca2+i (Fig. 2A) and inositol phosphate responses (Fig. 2B). ADP induced only a small Ca2+i response at high concentrations. UDP had no substantial effect.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Concentration-effect curves for nucleotide-stimulated Ca2+ responses (Delta Ca2+i) and [3H]inositol phosphate formation in mouse lung fibroblasts. Cells isolated from wild type (A, B) and P2Y2-R(-/-) mice (C, D) were exposed to the indicated concentration of ATP (), UTP (black-square), ADP (black-down-triangle ), or UDP (black-triangle). Changes in Ca2+i were measured immediately after the addition of agonist to Fura-2-loaded cells (top panels). Values are mean ± S.E. of changes from basal to peak concentration (n = 3-12/concentration). myo-[3H]Inositol-labeled cells were preincubated with LiCl and subsequently challenged with the indicated nucleotide for 15 min (B, D). Counts from accumulated [3H]inositol phosphates over the background were plotted. Each data point represents the mean ± S.E. of three independent experiments performed in triplicate.

Both Ca2+i and inositol phosphate responses to nucleotides were abolished in P2Y2-R(-/-) fibroblasts (Fig. 2, C and D). Similarly, ADP and UDP did not induce responses over background in these cells. These data indicate that the P2Y2 receptor is the only nucleotide receptor functionally expressed in murine lung fibroblasts.

Characterization of Nucleotide-induced Responses in Wild Type Airway Epithelial Cells-- Primary murine airway epithelial cells have a limited growth capacity. Therefore, in experiments with airway epithelia, we focused only on Ca2+i measurements and confined our pharmacologic characterizations to two concentrations of nucleotide agonists. The two concentrations (1 and 100 µM) of nucleotides studied were selected on the basis of previous studies of human nasal cells, where 100 µM ATP and UTP induced a maximal effect, and their EC50 values were in the low micromolar concentration range (3).

ATP and UTP promoted substantial Ca2+i responses at both 1 and 100 µM concentrations in tracheal cells from wild type mice (Fig. 3A). ADP, 2-MeSATP, and 2-MeSADP were effective only at the 100 µM concentration, while UDP had no measurable effect. A similar pattern was found in nasal cells (Fig. 3B), with the exception that, in the latter, the maximal responses to 100 µM agonist concentrations were generally smaller, whereas the 2-MeSATP and 2-MeSADP responses were relatively larger at the 1 µM concentration.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Nucleotide-induced Ca2+ responses (Delta Ca2+i) in wild-type murine tracheal (A) and nasal (B) epithelial cells. Changes in [Ca2+]i in response to 1 and 100 µM concentrations of the indicated nucleotide were measured in Fura-2-loaded airway epithelial cells isolated from wild type mice. Maximal changes in [Ca2+]i (from basal to peak) in response to the agonists were plotted (n = 3-14).

To investigate possible cross-desensitization between agonists in nucleotide-promoted Ca2+i responses, isolated tracheal and nasal cells were exposed first to successive additions of a 100 µM concentration of a given agonist until no further change in Ca2+i signal was observed. Subsequently, the cells were exposed to 100 µM of a second agonist in the continued presence of the first one.

The results obtained from wild type tracheal cells are shown in Fig. 4. UTP pretreatment markedly, but not completely, reduced the Ca2+i response to ATP (Fig. 4A), whereas ATP pretreatment completely abolished the UTP-induced Ca2+i response (Fig. 4B). Pretreatment with ADP, and 2-MeSATP had no significant effect on ATP or UTP-induced Ca2+i responses (Fig. 4, A and B). The Ca2+i signal elicited by 2-MeSATP was entirely abolished by ATP pretreatment (Fig. 4C). UTP or 2-MeSADP pretreatment also reduced, although only partially, the 2-MeSATP-induced responses. These findings suggest the functional expression of both a common receptor for ATP and UTP and an additional adenine nucleotide receptor(s).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Desensitization of nucleotide-stimulated Ca2+ responses in wild type tracheal and nasal epithelial cells. A, B, and C, tracheal Ca2+ responses induced by 100 µM ATP, UTP, or 2-MeSATP were measured following no preaddition (None) or preaddition of a 100 µM concentration of the nucleotides indicated at the bottom of each column. Responsiveness of the cells was tested by adding 200 µM carbachol after each individual experiment. The values are mean ± S.E. (n = 3-7). D, E, and F, desensitization studies with wild type nasal epithelial cells were performed with the same protocol detailed above. The values are mean ± S.E. (n = 3-6). The asterisks indicate significant differences between responses with or without pretreatment (p < 0.05). n.d., not determined)

Fig. 4 also summarizes the desensitization experiments performed with wild type nasal epithelial cells. A partial cross-desensitization between ATP and UTP was observed in this cell type (Fig. 4, D and E). Pretreatment with ADP did not significantly alter the response induced by ATP or UTP, whereas 2-MeSATP pretreatment significantly attenuated both ATP- and UTP-stimulated signals. The Ca2+i response to 2-MeSATP was eliminated by ATP or 2-MeSADP pretreatment (Fig. 4F). Taken together, these results are also consistent with the expression of a common receptor for ATP and UTP and, possibly, an additional ADP receptor.

Nucleotide-induced Ca2+ Responses in Airway Epithelial Cells from P2Y2-R(-/-) Mice-- A potential candidate for the common ATP/UTP receptor in airway epithelial cells is the P2Y2 receptor. To test the involvement of P2Y2 receptor in the murine airway epithelium, Ca2+i studies were performed on tracheal and nasal cells isolated from P2Y2-R(-/-) mice. The UTP-induced Ca2+i responses were abolished in both tracheal (Fig. 5A) and nasal cells (Fig. 5B). The magnitude of ATP-stimulated Ca2+i responses was substantially reduced in P2Y2-R(-/-) tracheal and nasal epithelial cells, but residual Ca2+i responses were measurable. The reductions in the responses to 100 µM ATP in wild type and P2Y2-R(-/-) tracheal and nasal cells (Figs. 3 and 5, respectively) were 74.5 and 44.0% (p < 0.02), respectively.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of nucleotides on tracheal (A) and nasal (B) epithelial cells isolated from P2Y2-R(-/-) mice. For details, see the legend of Fig. 2.

ADP, 2-MeSATP, and 2-MeSADP elicited Ca2+i responses in both tracheal and nasal cells from P2Y2-R(-/-) mice, whereas UDP had no substantial effect in either. A slight reduction in responses induced by 100 µM ADP and 2-MeSATP was observed in the P2Y2-R(-/-) tracheal cells, but Ca2+i responses induced by 100 µM 2-MeSADP in both P2Y2-R(-/-) tracheal and nasal cells were not significantly different from that found in wild type cells.

These results clearly demonstrate that the P2Y2 receptor is the major but not the unique nucleotide receptor functionally expressed in murine tracheal and nasal epithelial cells.

Identification of the Residual Nucleotide Receptor in P2Y2-R(-/-) Airway Epithelial Cells-- Next, we initiated a series of experiments to identify the nucleotide receptor type(s) that accounted for the residual Ca2+i responses induced by adenine nucleotides. To test for the involvement of adenosine receptors in ATP-promoted responses, P2Y2-R(-/-) cells were exposed to 100 µM ATP in the presence or absence of 1 unit/ml adenosine deaminase. In tracheal cells, ATP stimulated a 65.4 ± 17 nM (n = 3) change in Ca2+i in the presence of enzyme, which was not significantly different from the values obtained in its absence, 92.4 ± 40 nM (n = 10). In nasal cells, the ATP-induced Ca2+ responses were 103.8 ± 65 (n = 4) and 108.9 ± 29 nM (n = 11) in the presence and absence of adenosine deaminase, respectively. In addition, no Ca2+i response was elicited by 100 µM adenosine in either tracheal or nasal epithelial cells (1.5 ± 1.0 and 4.2 ± 0.2 nM, respectively (n = 3)).

Next, we tested for the possible involvement of P2X receptors (36). To investigate this issue, 100 µM alpha ,beta -meATP was applied to the P2Y2-R(-/-) tracheal and nasal cells. No Ca2+i response was elicited by this compound in either cell type (Delta Ca2+i in nose, 5.2 ± 3.9 nM, n = 3; Delta Ca2+i in trachea, 4.8 ± 1.0 nM, n = 5). Further, ATP-induced Ca2+i responses in Ca2+-free buffer were not different from those found in the presence of 1.3 mM Ca2+ in either wild type (Fig. 6A) or P2Y2-R(-/-) (Fig. 6B) epithelial cells. These results strongly suggest that P2X receptors do not mediate the residual ATP-induced responses.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of extracellular Ca2+ on the ATP-induced Ca2+ response in tracheal and nasal epithelial cells. Cells isolated from wild type (A) and P2Y2-R(-/-) (B) mice were challenged with 100 µM ATP in the presence and absence of extracellular Ca2+ (n = 3-11).

Cross-desensitization experiments with P2Y2-R(-/-) tracheal cells indicate that the Ca2+i response to ATP was eliminated when the cells were pretreated with ADP or 2-MeSATP but not with UTP (Fig. 7A). Similarly, pretreatment with ATP or 2-MeSADP entirely abolished the 2-MeSATP-induced response in these cells (Fig. 7B). Studies with P2Y2-R(-/-) nasal cells produced comparable results; pretreatment with ADP, 2-MeSATP, or 2-MeSADP abolished the ATP-induced Ca2+i signal (Fig. 7C). Similarly, the Ca2+i response to 2-MeSATP was eliminated when cells were pretreated with ATP, ADP, or 2-MeSADP (Fig. 7D). These results suggest one common receptor for ATP, ADP, 2-MeSATP, and 2-MeSADP in the P2Y2-R(-/-) tracheal and nasal epithelial cells. This pattern of agonists resembles the nucleotide-agonist profile of P2Y1 receptor described in many species, including the murine P2Y1 receptor (37).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Desensitization studies in P2Y2-R(-/-) tracheal and nasal epithelial cells. A, tracheal cell Ca2+ responses induced by 100 µM ATP (A) or 2-MeSATP (B) following no preaddition (None), or preaddition of 100 µM of nucleotide indicated at the bottom of each column. Similar protocols were used with nasal epithelial cells (C, D). The experiments were carried out as described in the legend of Fig. 3. The values are mean ± S.E. (n = 3-7). The asterisks indicate significant differences between responses with or without pretreatment (p < 0.05). n.d., not determined.

To directly investigate the involvement of the P2Y1 receptor in P2Y2-R(-/-) airway epithelial Ca2+i signaling, the effect of A3P5P, a P2Y1 receptor-selective antagonist (38), on the 2-MeSADP-induced Ca2+i responses was studied (Fig. 8). 2-MeSADP (1 µM) induced substantial Ca2+i responses in both wild type (Fig. 8A) and P2Y2-R(-/-) tracheal cells (Fig. 8B). The mean values for 2-MeSADP-induced changes in Ca2+i were 74.9 ± 23.2 nM (n = 7) and 50.4 ± 17.4 nM (n = 7) for wild type and P2Y2-R(-/-) mice, respectively. A3P5P (100 µM) alone did not stimulate Ca2+ responses, but it completely blocked the effect of 2-MeSADP (Fig. 8, right traces). The 2-MeSADP-induced changes in Ca2+i in the presence of A3P5P were significantly reduced compared with responses without A3P5P: 9.8 ± 5.0 nM (n = 3) and 8.9 ± 3.7 nM (n = 4) in wild type and P2Y2-R(-/-) cells, respectively. Similar inhibitory effects of A3P5P were observed in P2Y2-R(-/-) nasal epithelial cells; the mean changes in Ca2+i in response to 1 µM 2-MeSADP were 91.2 ± 23.5 nM (n = 3) and 6.5 ± 2.5 nM (n = 3) in the absence and presence of A3P5P, respectively. In contrast, A3P5P did not affect the UTP-stimulated Ca2+i response in wild type cells (Fig. 8A), consistent with the lack of effect of A3P5P on the P2Y2 receptor. Moreover, the carbachol-induced response in the P2Y2-R(-/-) cells also were not affected by A3P5P (Fig. 8B), further excluding nonspecific effects of A3P5P on Ca2+i signaling. Taken together, these data suggest that the residual P2 receptor in the P2Y2-R(-/-) murine airway epithelia is the P2Y1 receptor.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of A3P5P on the 2-MeSADP-induced Ca2+ response in mouse tracheal epithelial cells. Wild type (A) and P2Y2(-/-) (B) mouse tracheal cells were exposed to 1 µM 2-MeSADP in the presence and absence of 100 µM A3P5P. Responsiveness of the cells was tested by adding 100 µM UTP in wild type or 1 mM carbachol in P2Y2-R(-/-) cells at the completion of each experiment. The traces are representative of seven independent experiments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The murine P2Y2-R gene was disrupted by homologous recombination in embryonic stem lines and mice homozygous for the disrupted P2Y2-R gene generated from these lines. These P2Y2-R-deficient mice provide a unique tool for characterization of extracellular nucleotide regulation of cell signaling.

We investigated three different cell types isolated from lungs of wild type and P2Y2 receptor (-/-) mice: lung fibroblasts and tracheal and nasal epithelial cells. Because of the absence of specific and potent antagonists, binding assays have not been useful in studies characterizing tissue-specific expression of nucleotide receptors (39). Therefore, we have measured nucleotide-induced Ca2+ responses and, when possible, inositol lipid hydrolysis to characterize nucleotide receptor function in cells from these wild type and P2Y2 receptor-deficient mice.

A good correlation between Ca2+i responses and inositol phosphate formation was observed in lung fibroblasts (Fig. 2, A and B). The dose-effect relationships for nucleotide agonists and Ca2+i and inositol phosphate measurements were identical. The rank orders of agonist potencies (UTP >=  ATP >> ADP > UDP) were similar in both assays and were consistent with the pharmacological profile of the P2Y2 receptor. However, the recently cloned rat P2Y4 receptor displays a similar pattern of triphosphate nucleotide responses (40, 41), raising the possibility that its mouse homologue may do so as well.

A definitive description of which nucleotide receptor subtype(s) accounted for the effect of UTP and ATP in the murine lung fibroblast resulted from the experiments with cells isolated from P2Y2-R(-/-) mice (Fig. 2, C and D). These data, demonstrating that disruption of the gene encoding the P2Y2 receptor completely abolished nucleotide-induced inositol phosphate and Ca2+ responses, establish that the P2Y2 is the only P2 receptor functionally expressed in mouse lung fibroblasts. Further studies will be required to extend this characterization to nonlung fibroblasts and the potential influence of continuous culture to assess the relevance of this conclusion to those in previous reports.

Because of smaller numbers and limited growth capacity of the epithelial cells, we focused on nucleotide-induced Ca2+i responses rather than on inositol lipid hydrolysis in this cell type. Tracheal epithelial cells from wild type mice exhibited a rank order of nucleotide-induced responses (Fig. 3A) similar to that reported with the cloned human and mouse P2Y2 receptor (7, 10). Desensitization studies carried out with wild type tracheal cells provided further support for the hypothesis that a common UTP/ATP receptor is expressed in these cells (Fig. 4).

Direct, unambiguous evidence for P2Y2 expression in the murine trachea was provided by studies with P2Y2-R(-/-) tracheal cells. The complete abolition of UTP-induced Ca2+i responses clearly demonstrated that P2Y2 receptor accounted for the effect of UTP in wild type tracheal cells, and no other UTP-activated receptor (i.e. P2Y4 receptor) was present (Fig. 5A). The absence of effect of UDP in the P2Y2-R(-/-) cells also ruled out involvement of P2Y6 receptors. The major (75%) reduction in ATP-stimulated Ca2+ response clearly demonstrated that P2Y2 receptor was the predominant but not unique receptor for ATP in this cell type. The reduction in the magnitude of the response to 2-MeSATP suggests that this nonselective P2Y1/P2X receptor agonist also stimulates the P2Y2 receptor at high concentrations. This observation is consistent with the effect of 2-MeSATP reported with the cloned P2Y2 receptor (10).

Mouse nasal epithelial cells exhibited a profile of nucleotide-stimulated responses similar to that observed in tracheal cells (Figs. 3 and 4). The ATP/UTP responses were generally larger in wild type tracheal cells than in nasal cells, whereas the magnitude of residual ATP-stimulated responses in P2Y2-R(-/-) cells was similar in cells from each region (Fig. 5). This observation suggests a higher level of expression of the P2Y2 receptor in tracheal cells than nasal cells.

A second objective of our study was to identify additional nucleotide receptor(s) that might be expressed in mouse airway epithelial cells. The absence of specific agonists and antagonists for most of the P2 receptors makes it difficult to classify multiple receptors in a complex system. However, the P2Y2-R(-/-) mouse model facilitated these studies.

Our results provide direct evidence for the functional expression of P2 receptor(s) other than P2Y2 that are activated by adenine nucleotide agonists in murine tracheal and nasal epithelial cells. The involvement of P1 adenosine receptors in the ATP-induced Ca2+ response was ruled out on the bases that adenosine did not stimulate elevation in intracellular Ca2+ levels and that adenosine deaminase pretreatment did not affect the response to ATP in P2Y2-R(-/-) cells. alpha ,beta -meATP, originally thought to be specific for all P2X receptors (4), is now known to be active only at P2X1 and P2X3 receptors (36, 42, 43). In mouse airway epithelial cells, alpha ,beta -meATP was inactive in terms of Ca2+ signaling (see "Results") as well as Cl- secretion (33). We cannot entirely rule out the involvement of P2X receptors solely on the basis of the absence of alpha ,beta -meATP-induced responses. However, the experiments carried out in Ca2+-free buffer (Fig. 6) clearly demonstrated that ATP-stimulated Ca2+ responses primarily reflected release from internal stores and not direct opening of plasma membrane P2X (Ca2+) channels. These findings strongly suggest that the P2X receptors are not functionally expressed in these cells.

The residual effects of ATP, ADP, 2-MeSATP, and 2-MeSADP found in P2Y2-R(-/-) cells (Fig. 5), coupled with the desensitization studies (Fig. 7), are more consistent with the expression of P2Y1 receptor (44-46) than a P2Y11 receptor, because the latter is not activated by the diphosphate analogues (13). The substantial Ca2+i responses elicited by ADP and 2-MeSADP in the P2Y2-R(-/-) cells (Fig. 5), coupled with the antagonistic effect of A3P5P on the Ca2+i response to 2-MeSADP-induced responses (Fig. 8), strongly supports the hypothesis that the residual nucleotide receptor in the P2Y2-R(-/-) airway cells is in fact the P2Y1 receptor.

The results of Ca2+i measurements with tracheal epithelial cells can be compared with the data obtained from the tracheal Cl- secretory studies in the accompanying paper (33). Our studies were carried out on isolated tracheal cells grown on glass coverslips, providing access of added agonists to apical and basolateral membrane surfaces. In contrast, the Cl- measurements were performed with freshly excised tracheas with additions only to the apical surface. Despite these differences, the pharmacological profiles determined by theses two methods were generally similar in tracheal specimens and revealed that the P2Y2 receptor was the dominant receptor mediating both Ca2+i and Cl- secretory responses in wild type mice. A slight difference was that in P2Y2-R(-/-) tracheal epithelia UDP had a minor but potent effect on Cl- secretion (33), whereas negligible UDP responses were observed in the Ca2+i studies (Fig. 5). The simplest explanation for this discrepancy is that the UDP-activated receptor, probably P2Y6, was down-regulated during culture on glass coverslips.

In summary, murine lung fibroblasts as well as tracheal and nasal epithelial cells from wild type mice exhibit P2Y2-like pharmacologic responses to extracellular nucleotide additions. Comparative studies of cells from P2Y2-R(+/+) and P2Y2-R(-/-) mice provided direct evidence for P2Y2 receptor function in all three cell types. The P2Y2 receptor appears likely to be the only P2 receptor in mouse lung fibroblasts and is the predominant P2 receptor in airway epithelial cells. In addition, the P2Y2-R(-/-) mouse model made it possible to functionally characterize and identify another P2 receptor in airway epithelia, which was masked by the activity of the dominant P2Y2 receptor. The residual nucleotide receptor in mouse tracheal and nasal epithelial cells is most likely the P2Y1 receptor. Although conclusions regarding humans cannot be directly drawn from studies performed in mice, the P2Y2-R(-/-) mouse model system provides a unique tool for tissue-specific nucleotide receptor function.

    ACKNOWLEDGEMENTS

We are grateful to Drs. Barbara R. Grubb, James R. Yankaskas, and Anthony M. Paradiso for helpful advice and contribution to the isolation and culturing of murine pulmonary cells. We also thank Diana L. Walstad for technical assistance.

    FOOTNOTES

* Supported by National Institutes of Health (NIH) Grants HL58554 and DK51791 (to B. H. K.), NIH Grant HL34322, and Cystic Fibrosis Foundation Grants R026 and HOMOLY98I0.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Cystic Fibrosis/Pulmonary Research and Treatment Center, CB 7248, 7011 Thurston-Bowles Building, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7248. Tel.: 919-966-1077; Fax: 919-966-7524; E-mail: rboucher@med.unc.edu.

    ABBREVIATIONS

The abbreviations used are: P2Y2-R, P2Y2 receptor; 2-MeSATP, 2-methylthioadenosine 5'-triphosphate; 2-MeSADP, 2-methylthioadenosine 5'-diphosphate; alpha ,beta -meATP, alpha ,beta -methylene adenosine 5'-triphosphate; A3P5P, adenosine 3',5'-diphosphate; EC50, 50% of maximal effective concentration; SSC, sodium chloride-sodium citrate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Gordon, J. L. (1986) Biochem. J. 233, 309-319[Medline] [Order article via Infotrieve]
2. Dubyak, G. R., and El-Moatassim, C. (1993) Am. J. Physiol. 265, C577-C606[Abstract/Free Full Text]
3. Mason, S. J., Paradiso, A. M., and Boucher, R. C. (1991) Br. J. Pharmacol. 103, 1649-1656[Medline] [Order article via Infotrieve]
4. Burnstock, G., and Kennedy, C. (1985) Gen. Pharmacol. 16, 433-440[Medline] [Order article via Infotrieve]
5. Zeiske, W. (1978) Biochim. Biophys. Acta 509, 218-229[Medline] [Order article via Infotrieve]
6. Seifert, R., and Schultz, G. (1989) Trends Pharmacol. Sci. 10, 365-369[CrossRef][Medline] [Order article via Infotrieve]
7. Lustig, K. D., Shiau, A. K., Brake, A. J., and Julius, D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 5113-5117[Abstract/Free Full Text]
8. Parr, C. E., Sullivan, D. M., Paradiso, A. M., Lazarowski, E. R., Burch, L. H., Olsen, J. C., Erb, L., Weisman, G. A., Boucher, R. C., and Turner, J. T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3275-3279[Abstract/Free Full Text]
9. Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q., and Harden, T. K. (1996) Mol. Pharmacol. 50, 224-229[Abstract]
10. Lazarowski, E. R., Watt, W. C., Stutts, M. J., Boucher, R. C., and Harden, T. K. (1995) Br. J. Pharmacol. 116, 1619-1627[Medline] [Order article via Infotrieve]
11. Harden, T. K., Boyer, J. L., and Nicholas, R. A. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 541-579[CrossRef][Medline] [Order article via Infotrieve]
12. Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Dubyak, G. R., Harden, T. K., Jacobson, K. A., Schwabe, U., and Williams, M. (1997) Trends Pharmacol. Sci. 18, 79-82[Medline] [Order article via Infotrieve]
13. Communi, D., Govaerts, C., Parmentier, M., and Boeynaems, J. M. (1997) J. Biol. Chem. 272, 31969-31973[Abstract/Free Full Text]
14. Okada, Y., Yada, T., Ohno-Shosaku, T., Oiki, S., Ueda, S., and Machida, K. (1984) Exp. Cell Res. 152, 552-557[CrossRef][Medline] [Order article via Infotrieve]
15. Rathbone, M. P., Middlemiss, P. J., Gysbers, J. W., DeForge, S., Costello, P., and Del Maestro, R. F. (1992) In Vitro Cell. Dev. Biol. 28A, 529-536
16. Joseph, J., Grierson, I., and Hitchings, R. A. (1988) Exp. Cell Res. 176, 1-12[CrossRef][Medline] [Order article via Infotrieve]
17. Gonzalez, F. A., Bonapace, E., Belzer, I., Friedberg, I., and Heppel, L. A. (1989) Biochem. Biophys. Res. Commun. 164, 706-713[CrossRef][Medline] [Order article via Infotrieve]
18. Pizzo, P., Murgia, M., Zambon, A., Zanovello, P., Bronte, V., Pietrobon, D., and Di Virgilio, F. (1992) J. Immunol. 149, 3372-3378[Abstract]
19. Erb, L., Lustig, K. D., Ahmed, A. H., Gonzalez, F. A., and Weisman, G. A. (1990) J. Biol. Chem. 265, 7424-7431[Abstract/Free Full Text]
20. Gubits, R. M., Wollack, J. B., Yu, H., and Liu, W. K. (1990) Mol. Brain Res. 8, 275-281[Medline] [Order article via Infotrieve]
21. Rozengurt, E. (1982) Exp. Cell Res. 139, 71-78[CrossRef][Medline] [Order article via Infotrieve]
22. Tepel, M., Loewe, S., Nofer, J. R., Assmann, G., Schlueter, H., and Zidek, W. (1996) Biochim. Biophys. Acta 1312, 145-150[Medline] [Order article via Infotrieve]
23. Giovannardi, S., Racca, C., Bertollini, L., Sturani, E., and Peres, A. (1992) Exp. Cell Res. 202, 398-404[CrossRef][Medline] [Order article via Infotrieve]
24. Fine, J., Cole, P., and Davidson, J. S. (1989) Biochem. J. 263, 371-376[Medline] [Order article via Infotrieve]
25. Jiang, C., Finkbeiner, W. E., Widdicombe, J. H., McCray, P. B., Jr., and Miller, S. S. (1993) Science 262, 424-427[Abstract/Free Full Text]
26. Lethem, M. I., Dowell, M. L., Van Scott, M., Yankaskas, J. R., Egan, T., Boucher, R. C., and Davis, C. W. (1993) Am. J. Respir. Cell Mol. Biol. 9, 315-322
27. Davis, C. W., Dowell, M. L., Lethem, M. I., and Van Scott, M. (1992) Am. J. Physiol. 262, C1313-C1323[Abstract/Free Full Text]
28. Geary, C. A., Davis, C. W., Paradiso, A. M., and Boucher, R. C. (1995) Am. J. Physiol. 268, L1021-L1028[Abstract/Free Full Text]
29. Brown, H. A., Lazarowski, E. R., Boucher, R. C., and Harden, T. K. (1991) Mol. Pharmacol. 40, 648-655[Abstract]
30. Benali, R., Pierrot, D., Zahm, J. M., de Bentzmann, S., and Puchelle, E. (1994) Am. J. Respir. Cell Mol. Biol. 10, 363-368[Abstract]
31. Lazarowski, E. R., Paradiso, A. M., Watt, W. C., Harden, T. K., and Boucher, R. C. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 2599-2603[Abstract/Free Full Text]
32. Lazarowski, E. R., Mason, S. J., Clarke, L. L., Harden, T. K., and Boucher, R. C. (1992) Br. J. Pharmacol. 106, 774-782[Medline] [Order article via Infotrieve]
33. Cressman, V. L., Lazarowski, E., Homolya, L., Boucher, R. C., Koller, B. H., and Grubb, B. R. (1999) 274, 26461-26468
34. Paradiso, A. M., Mason, S. J., Lazarowski, E. R., and Boucher, R. C. (1995) Nature 377, 643-646[CrossRef][Medline] [Order article via Infotrieve]
35. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract/Free Full Text]
36. Evans, R. J., Surprenant, A., and North, R. A. (1998) in The P2 Nucleotide Receptors (Turner, J. T. , Weisman, G. A. , and Fedan, J. S., eds) , pp. 43-61, Humana Press, Totowa, NJ
37. Tokuyama, Y., Hara, M., Jones, E. M. C., Fan, Z., and Bell, G. I. (1995) Biochem. Biophys. Res. Commun. 211, 211-218[CrossRef][Medline] [Order article via Infotrieve]
38. Boyer, J. L., Romero-Avila, T., Schachter, J. B., and Harden, T. K. (1996) Mol. Pharmacol. 50, 1323-1329[Abstract]
39. Schachter, J. B., and Harden, T. K. (1997) Br. J. Pharmacol. 121, 338-344[CrossRef][Medline] [Order article via Infotrieve]
40. Webb, T. E., Henderson, D. J., Roberts, J. A., and Barnard, E. A. (1998) J. Neurochem. 71, 1348-1357[Medline] [Order article via Infotrieve]
41. Bogdanov, Y. D., Wildman, S. S., Clements, M. P., King, B. F., and Burnstock, G. (1998) Br. J. Pharmacol. 124, 428-430[CrossRef][Medline] [Order article via Infotrieve]
42. Valera, S., Hussy, N., Evans, R. J., Adami, N., North, R. A., Surprenant, A., and Buell, G. (1994) Nature 371, 516-519[CrossRef][Medline] [Order article via Infotrieve]
43. Chen, C. C., Akopian, A. N., Sivilotti, L., Colquhoun, D., Burnstock, G., and Wood, J. N. (1995) Nature 377, 428-431[CrossRef][Medline] [Order article via Infotrieve]
44. Webb, T. E., Simon, J., Krishek, B. J., Bateson, A. N., Smart, T. G., King, B. F., Burnstock, G., and Barnard, E. A. (1993) FEBS Lett. 324, 219-225[CrossRef][Medline] [Order article via Infotrieve]
45. Filtz, T. M., Li, Q., Boyer, J. L., Nicholas, R. A., and Harden, T. K. (1994) Mol. Pharmacol. 46, 8-14[Abstract]
46. Schachter, J. B., Li, Q., Boyer, J. L., Nicholas, R. A., and Harden, T. K. (1996) Br. J. Pharmacol. 118, 167-173[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
I. M. Lorenzo, W. Liedtke, M. J. Sanderson, and M. A. Valverde
TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells
PNAS, August 26, 2008; 105(34): 12611 - 12616.
[Abstract] [Full Text] [PDF]